Tel.:
+34 91 736 2385
LOCAL TIME
Contact:
Katarina Gluic
Hours:
Mon-Thu 8:30-17:00 Fri 8:30-15:00
08:36
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments
51st ERA-EDTA CONGRESS
31 May - 3 June 2014 AMSTERDAM
About us
FAQs
Help Line
Personal Area
Homepage
Discussion forum -
51st ERA-EDTA CONGRESS
Topic -
L) Renal pathology. L3) Renal histopathology.
If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
Thread / Poster
Author
Replies
Last reply
RETROPERITONEOSCOPIC RENAL NEEDLE BIOPSY FOR UNUSUAL STATUS PATIENTS
Takaaki Kimura
1
5/20/2014 3:10:00 PM
IMMUNOTACTOID GLOMEROLUPATHY: A CASE OF MONOCLONAL GAMMAPATHY OF RENAL SIGNIFICANCE
Egrina Dervishi
1
5/19/2014 6:06:00 PM
THE PROGRESSION OF MEDULLARY RAY INJURY IN KIDNEY AGING
Shinichi Nishi
1
5/19/2014 1:03:00 PM
ASSOCIATION OF PROTEINURIA AND MDRD-GFR WITH HISTOLOGICAL PARAMETERS GRADED ACCORDING TO OXFORD CLASSIFICATION IN PATIENTS WITH IGA NEPHROPATHY.
Charan Bale
1
5/17/2014 1:01:00 PM
KIDNEY DISEASE IN ITALIAN HIV PATIENTS: SOMETHING MORE THAN HIVAN
Gianni Cappelli
1
5/5/2014 3:14:00 PM
THE CHANGE IN GLOMERULAR VOLUME AND ITS CLINICOPATHOLOGICAL IMPACT AFTER KIDNEY TRANSPLANTATION
Akimitsu Kobayashi
1
5/1/2014 7:57:00 AM
Most viewed poster for this congress
Poster:
7
Visits:
477
Title:
SEVERE SYMPTOMATIC ACUTE HYPONATREMIA IN TRAUMATIC BRAIN INJURY RESPONDS VERY RAPIDLY SINGLE 15 MG DOSE OF TOLVAPTAN: A MAYO CLINIC HEALTH SYSTEM HOSPITAL EXPERIENCE - NEED FOR CAUTION WITH TOLVAPTAN IN YOUNGER PATIENTS WITH PRESERVED RENAL FUNCTION
Authors:
MACAULAY ONUIGBO ,
Centre:
MAYO CLINIC, ROCHESTER & MAYO CLINIC HEALTH SYSTEM, EAU CLAIRE
Poster most viewed in this topic
Poster:
381
Visits:
47
Title:
IMMUNOTACTOID GLOMEROLUPATHY: A CASE OF MONOCLONAL GAMMAPATHY OF RENAL SIGNIFICANCE
Authors:
Egrina Dervishi ,
Centre:
Nephrology Unit, Careggi University Hospital Florence, Italy
About us
Terms and Conditions
Special Access
Commercial Web Access
Follow us on: